Albany, NY -- (SBWIRE) -- 12/18/2017 -- Out of the drug class segments, bisphosphonates were the fastest growing segment and held 48.2% of the overall osteoporosis drugs market in 2013. However, analysts predict that pipeline drugs will showcase accelerated growth at a CAGR of 125.20% from 2014 to 2020.The International Osteoporosis Foundation (IOF) stated that at least 9 mn fractures and bone cracks occur every year. In addition to this, about 200 mn women across the world are expected to be victims of osteoporosis with each passing year. With these alarming figures, growth of the global osteoporosis drug is only expected to accelerate. In addition, introduction of new drug classes that hold the promise of overcoming the threat of chronic and generics side effects of the established drugs is yet another factor making a positive influence on the growth of the global osteoporosis drugs market.

The global Osteoporosis Drugs Market is segmented on the basis of Drug Class, Geography.

On the basis of drug class, the global osteoporosis market is segmented into bisphosphonates, parathyroid hormone therapy (PTH) drugs, selective estrogen receptor modulators (SERMs), RANK ligand inhibitors, calcitonin, and other such as others Vitamin D and calcium. This segment also includes drugs that are in the pipeline. Geographically, this market is segmented into Europe, North America, Asia Pacific, and Rest of the World.

In terms of geography, North America holds a major share in the global osteoporosis drugs market. This can be credited to the presence of a huge pool of patients suffering from osteoporosis, growing awareness about the disease, technological advancements and adoption of the same, and presence of state-of-the-art medical infrastructure. However, the research report predicts that Asia Pacific will be the next region to create a huge wave of demand in the osteoporosis drugs market from 2014 to 2020.

Summary of Table of Content
1. Introduction
2. Executive Summary
3. Disease Overview: Osteoporosis
4. Market Overview
5. Global Osteoporosis Drugs Market Revenue, by Drugs Class 2012 – 2020 (USD Million)
6. Global Osteoporosis Dugs Market Revenue, by Geography, 2012 – 2020 (USD Million)
7. Recommendations
8. Company Profiles

Request to Browse Full Table of Content, figure and Tables @ https://www.transparencymarketresearch.com/report-toc/133